Who
Jose Manuel Otero
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, Lexeo Therapeutics.
In numbers
- Trades disclosed
- 32
- Buys
- 0
- Sells
- 8
- Bought
- $0
- Sold
- $159K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 12 Jun 2024
- Last trade
- 24 Sep 2026
- Last filed
- 28 Sep 2026
Companies traded
Activity over time
1 Aug 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Sep 2026filed 28 Sep 2026 | LXEO Lexeo Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —54,750 at $0.00 | filing |
| 24 Sep 2026filed 28 Sep 2026 | LXEO Lexeo Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —54,750 at $0.00 | filing |
| 14 Sep 2026filed 28 Sep 2026 | LXEO Lexeo TherapeuticsBiotechnology | SEC FORM 4 Code A | $5,5792,110 at $2.64 | filing |
| 14 Sep 2026filed 28 Sep 2026 | LXEO Lexeo TherapeuticsBiotechnology | SEC FORM 4 Code A | $5,5702,110 at $2.64 | filing |
| 18 Aug 2026filed 19 Aug 2026 | LXEO Lexeo TherapeuticsBiotechnology | SEC FORM 4 Sold | $6,4641,304 at $4.96 | filing |
| 18 Aug 2026filed 19 Aug 2026 | LXEO Lexeo TherapeuticsBiotechnology | SEC FORM 4 Sold | $6,4681,304 at $4.96 | filing |
| 1 Jul 2026filed 1 Jul 2026 | LXEO Lexeo TherapeuticsBiotechnology | SEC FORM 4 Sold | $21K4,666 at $4.48 | filing |
| 1 Jul 2026filed 1 Jul 2026 | LXEO Lexeo TherapeuticsBiotechnology | SEC FORM 4 Sold | $21K4,666 at $4.48 | filing |
| 29 Jun 2026filed 1 Jul 2026 | LXEO Lexeo TherapeuticsBiotechnology | SEC FORM 4 Code A | —12,060 at $0.00 | filing |
| 29 Jun 2026filed 1 Jul 2026 | LXEO Lexeo TherapeuticsBiotechnology | SEC FORM 4 Code A | —12,060 at $0.00 | filing |
| 18 May 2026filed 20 May 2026 | LXEO Lexeo TherapeuticsBiotechnology | SEC FORM 4 Sold | $6,6061,302 at $5.07 | filing |
| 18 May 2026filed 20 May 2026 | LXEO Lexeo TherapeuticsBiotechnology | SEC FORM 4 Sold | $6,6011,302 at $5.07 | filing |
| 13 Mar 2026filed 17 Mar 2026 | LXEO Lexeo TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K5,930 at $2.64 | filing |
| 13 Mar 2026filed 17 Mar 2026 | LXEO Lexeo TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K5,930 at $2.64 | filing |
| 18 Feb 2026filed 20 Feb 2026 | LXEO Lexeo TherapeuticsBiotechnology | SEC FORM 4 Sold | $19K3,016 at $6.40 | filing |
| 18 Feb 2026filed 20 Feb 2026 | LXEO Lexeo TherapeuticsBiotechnology | SEC FORM 4 Sold | $19K3,016 at $6.40 | filing |
| 4 Feb 2026filed 6 Feb 2026 | LXEO Lexeo TherapeuticsBiotechnology | SEC FORM 4 Code A | —65,000 at $0.00 | filing |
| 4 Feb 2026filed 6 Feb 2026 | LXEO Lexeo Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —260,000 at $0.00 | filing |
| 4 Feb 2026filed 6 Feb 2026 | LXEO Lexeo Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —260,000 at $0.00 | filing |
| 4 Feb 2026filed 6 Feb 2026 | LXEO Lexeo TherapeuticsBiotechnology | SEC FORM 4 Code A | —65,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.